0001437749-25-026516
SEC filingExport restrictions and unfavorable yields drove a 35.6% revenue decline and gross margin slump to 8.0%.
Revenue for the three months ended June 30, 2025 was $18.0 million, a decrease of 35.6% compared to $27.9 million in the same period last year. The decline was primarily due to export restrictions imposed by China on indium phosphide (InP) and gallium arsenide (GaAs) substrates, which reduced demand across several regions. Gross profit fell 81.3% to $1.4 million, with gross margin collapsing from 27.4% to 8.0%. This steep drop was caused by significant unfavorable yields charged to cost of goods sold in GaAs production lines and unabsorbed overhead from lower substrate revenue. Selling, general and administrative expenses decreased marginally by 2.2% to $5.7 million, while research and development expenses dropped 32.8% to $2.5 million due to lower product development costs. Interest expense declined 28.4% to $0.2 million on higher interest income. The loss from equity method investments was $0.2 million versus a gain of $0.6 million a year ago, and other income fell 95.3% to $23,000 due to fewer government grants. Provision for income taxes increased to $0.6 million, reflecting foreign taxes and minimum state taxes.
Substrate revenue decreased 42.8% to $11.3 million, driven by lower demand for InP wafer substrates used in data centers and passive optical networks due to export restrictions, weaker GaAs demand across applications, and softer Ge demand in China. Raw materials revenue declined 18.3% to $6.7 million, primarily from lower sales of refined gallium and pBN crucibles due to weak market demand. Geographic revenue showed broad weakness: China (-14.5%), Taiwan (-84.5%), Japan (-11.6%), Asia Pacific (-40.0%), Europe (-65.9%), and North America (-83.5%). The North America drop was especially severe as InP and GaAs shipments were hindered by export controls. For the six months, substrate revenue fell 38.9% to $22.4 million, while raw materials revenue grew 7.1% to $15.0 million due to increased refined gallium and recycled material sales.
Management highlighted ongoing uncertainties from trade tensions and export regulations. On June 11, 2025, Tongmei received initial export permits for InP substrates to certain customers in Europe and Japan, and later for the UK and Canada. However, permits for the US remain pending, and the timing is uncertain. Tariffs on Chinese imports have escalated to approximately 100%, further pressuring US sales. The company believes it has adequate liquidity ($35.1 million in cash and restricted cash) to meet needs over the next 12 months, but warns that further sales declines could strain cash flows. No specific numeric guidance was provided, but management expects tariffs and export restrictions to negatively impact revenues, profitability, and cash flows.
As of June 30, 2025, AXT held $35.1 million in total cash (including $8.1M restricted), down slightly from $33.8M at year-end 2024. The company carries no marketable securities. Total debt stood at $60.9 million, comprising $55.9M short-term loans and $5.0M long-term loans, up from $47.3M short-term and $4.6M long-term at December 31, 2024. Stockholders' equity decreased to $202.6M from $216.3M, driven by net losses and dividends. Inventory was $80.1M, with reserves of $26.5M for excess/obsolete.
The Notes detail several significant commitments: a cross license agreement with annual payments through 2029 (amounts not aggregated); land purchase/investment agreements with Dingxing ($90M total targeted), Kazuo ($15M), and BoYu ($8M), though no firm deadlines or penalties. No purchase order cancellation penalties exist. Lease obligations total $2.5M in minimum payments.
AXT has a $5.0M stock repurchase authorization, with $2.7M remaining; no shares were repurchased in H1 2025. No common dividends are paid; preferred cumulative dividends of $2.9M are accrued. Debt activity: $24.4M in new short-term borrowings and $2.8M in long-term, offset by repayments of $20.2M short-term and $0.5M long-term. Capex was $0.8M (2.1% of sales), primarily for construction projects in Dingxing and Kazuo.
AXT operates as a single segment. Product revenue: substrates $22.4M (down 39% YoY), raw materials $15.0M (up 7%). Geographically, China accounted for 75% of H1 revenue ($27.9M), followed by Europe ($3.7M), Taiwan ($1.8M), Japan ($1.4M), and North America ($1.3M). Long-lived assets are concentrated in China ($160.7M) vs. North America ($1.2M).
AXT's net loss of $17.7M was significantly larger than the $7.9M cash used in operations, due to non-cash adjustments: depreciation ($4.5M), stock-based comp ($1.3M), and equity method gains. Working capital provided a net $3.3M boost from decreases in accounts receivable, inventories, and prepaids, partially offset by declines in payables and accrued liabilities.
Capital expenditures dropped sharply to $0.8M from $4.7M, indicating reduced investment in fixed assets. This helped narrow the cash burn.
No share repurchases or dividends were paid. Financing activities provided $6.6M net, mainly from short-term bank loans, offsetting operating cash outflows.
The effect of exchange rate changes contributed $4.3M positive to cash, a notable non-operational factor. Supplemental disclosures included $1.5M of notes receivable used for fixed asset purchases, representing non-cash investing activity.